Results 241 to 250 of about 178,253 (288)

Geographic expansion, not viral intensification, leads to human dengue outbreaks in Mexico: a 40-year integrated remote sensing and machine learning analysis. [PDF]

Front Public Health
Li H, Lee C, Sweeney S, Valafar H, Nolan MS.   +4 more
europepmc   +1 more source

Clinical and Analytical Performance of the AP Biotech Discovery^® Dengue Virus RT-PCR Detection Kit. [PDF]

Viruses
Hjelt V, Dronseck A, Schey AM, Martí MB, Civerchia L, Cavatorta AL, Codino E, Nader V, Garro NA, Aranda FM, Mammana L, Giamperetti S, Theaux C, Marchissio A, Burani VE, Luczak EN, Bellucci MM, García G, Cayrol F, Bouzas MB, Grutadauria S, Brocardo L.   +21 more
europepmc   +1 more source

Safety and Preliminary Efficacy of Dengue Monoclonal Antibody in Adult Patients: A Randomized Clinical Trial.

JAMA Netw Open
Kulkarni PS, Potey AV, Gupta SK, Kodre A, Basu I, Shukla V, Barge V, Munshi R, Mishra AC, Vadakkedath R, Oldach D, Reddy PS, Yeolekar L, Poonawalla CS, Dhere RM, Arankalle VA, Kulkarni R, Gunale B, Dengue-mAb-02 Study Group.   +18 more
europepmc   +1 more source

Dengue/dengue haemorrhagic fever.

Releve epidemiologique hebdomadaire, 2000
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dengue

The Lancet, 2019
Mortality from severe dengue is low, but the economic and resource burden on health services remains substantial in endemic settings. Unfortunately, progress towards development of effective therapeutics has been slow, despite notable advances in the understanding of disease pathogenesis and considerable investment in antiviral drug discovery.
Wilder-Smith, A, Ooi, E, Horstick, O, Wills, B   +3 more
openaire   +3 more sources

Dengue

The Lancet, 2015
Dengue viruses have spread rapidly within countries and across regions in the past few decades, resulting in an increased frequency of epidemics and severe dengue disease, hyperendemicity of multiple dengue virus serotypes in many tropical countries, and autochthonous transmission in Europe and the USA.
Maria G, Guzman, Eva, Harris
openaire   +2 more sources

Dengue vaccines: implications for dengue control

Current Opinion in Infectious Diseases, 2017
Purpose of review Dengue, the most common arbovirus, is an increasingly significant cause of morbidity worldwide. After decades of research, an approved tetravalent dengue vaccine is finally available. Models constructed using recently available vaccine efficacy data allow for a data-driven discussion of the potential impact of
Matthew L, Robinson, Anna P, Durbin
openaire   +2 more sources

Haematology in dengue and dengue haemorrhagic fever

Best Practice & Research Clinical Haematology, 2000
Dengue fever (DF) and dengue haemorrhagic fever (DHF) are caused by the dengue virus. The major pathophysiological hallmark that distinguishes DHF from DF is plasma leakage as a result of increased vascular permeability. Following this leakage, hypovolaemic shock occurs as a consequence of a critical plasma volume loss.
T, Srichaikul, S, Nimmannitya
openaire   +2 more sources